McKesson Absorbent Dressings Recalled Due to Temperature Storage Excursions
McKesson absorbent dressings manufactured by Derma Sciences are being recalled due to temperature excursions during storage from June to August 2021. The FDA states the affected dressings are not likely to cause adverse health consequences.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: This is an FDA Class III product with no reported illnesses or injuries. The source explicitly states the device is 'not likely to cause adverse health consequences' from the temperature deviation, making this a precautionary recall with theoretical hazard.
Plain-English summary
McKesson brand absorbent dressings, including packing strips, MediHoney dressings, DuPad pads, and Shur-Conform oil emulsion dressings manufactured by Derma Sciences Inc., are being recalled nationwide.
The recall is due to temperature excursions that occurred between June and August 2021 prior to product delivery. Facility temperatures exceeded normal storage parameters, which may have affected product effectiveness. The FDA has determined that this specific temperature deviation is not likely to cause adverse health consequences.
All product lots received between June 1, 2021, and September 30, 2021, are affected. These dressings were distributed nationwide throughout the United States.
Consumers and healthcare providers in possession of affected dressings should check their product information and contact McKesson Medical-Surgical Inc. for guidance on product replacement or proper disposal.
The recalled product
- Product
- Absorbent dressings. a. DERMA SCIENCES, INC. McKesson PACKING STRIP, PLAIN 1/4"X5YDSSTR LF (12 MGM61 61- Catalog #61-59120. b. DERMA SCIENCES, INC. McKesson PACKING STRIP, PLAIN 1/2"X5YDSSTR LF (12/CS) MGM61 Catalog #61-59220. c. DERMA SCIENCES, INC. McKesson PACKING STRIP, PLAIN
- Manufacturer
- Mckesson Medical-Surgical Inc. Corporate Office
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (7)
- GTIN: a. 10612479136066
- 40612479136074. b. 10612479136080
- 40612479136098. c. 10612479136103
- 40612479136111. d. 10381780486978
- 30381780486972. e. 00809958081907
- 00809958081914. f. 30381780491778
- 10381780491774
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 23 recalled by Mckesson Medical-Surgical Inc. Corporate Office under a single FDA (Devices) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 23 products in this recall →Related recalls
Same manufacturer · Mckesson Medical-Surgical Inc. Corporate Office
See all →- ModerateStrep A test kits recalled after shipment to unlicensed purchasing customers
FDA (Devices) · 2025-08-27
- ModerateProlia prefilled syringes recalled after potential temperature excursions during transit delays
FDA (Drugs) · 2025-07-30
- ModerateEvenity prefilled syringes recalled after potential temperature excursions during transit delays
FDA (Drugs) · 2025-07-30
- ModerateBenlysta vials recalled after potential temperature excursions during transit delays
FDA (Drugs) · 2025-07-30
- ModerateAbbott Diagnostics ARC Carbon Dioxide Calibrator Cold Chain Storage Issue
FDA (Devices) · 2025-06-04
Same hazard · temperature excursion
See all →- ModerateCyclophosphamide injection vials recalled after a transportation temperature excursion
FDA (Drugs) · 2025-09-24
- ModerateXolair 75 mg syringes exposed to temperatures outside labeled storage requirements
FDA (Drugs) · 2025-08-13
- ModerateRecombinate antihemophilic factor vials exposed to temperatures outside labeled storage
FDA (Drugs) · 2025-08-13
- ModerateXolair auto-injectors exposed to temperatures outside labeled storage requirements
FDA (Drugs) · 2025-08-13